KELLI STANLEY: Open Payments
NPI 1306436910 · AURORA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 21 payments from 9 companies in 2025. Trend: 2023 $706 · 2024 $1,654 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $180 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Edwards Lifesciences Corporation | 1 | $95 |
| Amgen Inc. | 1 | $68 |
| Novo Nordisk Inc | 2 | $52 |
| PFIZER INC. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
Products named: CAMZYOS, TRYVIO, SAPIEN 3 Ultra RESILIA, LEQVIO, REPATHA, ELIQUIS, VYNDAQEL, Wegovy.
Industry payments across IL — which companies pay providers there.
